Historically chemotherapy was the predominant treatment for advanced cancers, however within the last decade there has been an explosion of new systemic therapies that complement chemotherapy. These are often treatments that divide significantly fromchemotherapy in terms of how they are delivered and potential side-effects.

Some of these include:

  • Highly selective endocrine treatments for hormone responsive cancers (e.g. prostate cancer).
  • Small molecules known as tyrosine kinase inhibitors (TKI’s) which have activity on selective mutations in certain cancers.
  • Monoclonal antibodies (MABs) – which target cell surface receptors to manipulate cell signalling.

These include:

  • Immunotherapy (agents designed to activate the immune system to recognise and destroy the cancer).
  • Targeted agents which have the ability decrease the blood supply to the cancer, or to reduce the chance of fractures and pain resulting from cancer which has spread to the bone.

Clinical trials are running in Cairns and throughout the world which are likely to o’er more treatment options in the coming years.

Important Info

Warning: Illegal string offset 'treatment_tab_title' in /home/imedserv/public_html/ on line 53

Warning: Illegal string offset 'treatment_tab_data' in /home/imedserv/public_html/ on line 54